newsfilter
← Latest News
Business Wire·

Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

Ended Q1 2024 with $89.8 million in cash and closed oversubscribed $112.5 million private placement in April 2024 from new and existing leading life sciences institutional investors Appointed Robert Lisicki as CEO